AI Article Synopsis

  • The study aimed to determine the prevalence and risk factors of diabetic retinopathy (DR) among residents aged 40 and older in Luzhou, Sichuan Province, focusing on a sample of 8002 permanent residents.
  • Out of 7478 participants, 1374 were identified as diabetic, leading to a DR prevalence of 15.57%, with 90.65% of DR cases being non-proliferative.
  • Significant risk factors for DR included the duration of diabetes and levels of glycosylated hemoglobin (HbA1c), with statistical analyses confirming their relationship with the condition.

Article Abstract

Objective: To estimate the prevalence rate and risk factors of diabetic retinopathy(DR) in residents at the age of ≥ 40 years in Luzhou, Sichuan Province.

Methods: A multistage, stratified cluster random sampling method was used to select 7 communities of 8002 permanent residents ( ≥ 40 years old) for diabetes screened from May to December 2011 in Luzhou, Sichuan Province.Reference to the diagnostic criteria for diabetes recommended by World Health Organization in 1999, to the 1374 diabetes screening out patients with questionnaire, physical examination, fasting plasma glucose, 2-hours postprandial plasma glucose, glycosylated hemoglobin(HbAlc) and visual acuity, ocular diseases, fundus examination, etc.Some patients with fundus fluorescein angiography to the DR diagnosis, diagnostic criteria with reference to the diagnosis standard made by Chinese Ocular Fundus Diseases Society, Chinese Ophthalmological Society, Chinese Medical Association in 1984. Rates between the groups were compared using χ(2) test, trend χ(2) test or Fisher exact test, using multivariate analysis of risk factors associated with DR screening.

Results: A total of 8002 people were chosen and invited to take part in the project, 7478 persons completed the study, the overall response rate was 93.48%.One thousand three hundreds and seventy-four persons were diagnosed as diabetic patients, which took the proportion of 18.37% of the selected population, while 214 DR patients were found with the DR prevalence of 15.57%, occupying 2.86% of the total.Of 214 patients, 194 cases were non-proliferative diabetic retinopathy, making up 90.65% of DR patients, while 7 cases were found to be proliferative diabetic retinopathy, constitute 9.35% of DR patients. Multi-factor analysis manifest that there were close relationship between diabetic duration (trend χ(2) = 189.21, P < 0.01) , the level of HbAlc (χ(2) = 30.021, P < 0.01) , coronary heart disease (χ(2) = 4.075, P = 0.044) and DR prevalence.

Conclusions: The prevalence of DR is high in the diabetic residents in Luzhou, Sichuan Province. Diabetic duration, the level of HbAlc and coronary heart disease are the significant factors to influence DR development. These results indicate that the changes of the level of HbAlc are closely related to the genesis and development of DR among the diabetic patients.

Download full-text PDF

Source

Publication Analysis

Top Keywords

diabetic retinopathy
12
≥ years
12
luzhou sichuan
12
level hbalc
12
diabetic
9
age ≥
8
years luzhou
8
sichuan province
8
risk factors
8
diagnostic criteria
8

Similar Publications

Objective: This study aims to examine the reduction and subsequent recovery of routine digital screening (RDS) uptake in England from 2018 to 2022, exploring national, regional and individual Diabetic Eye Screening Programme (DESP) levels. The COVID-19 lockdown in most areas of England was from 26 March 2020 to 23 June 2020 (first national lockdown), 5 November 2020 to 2 December 2020 (second national lockdown) and 6 January 2021 to 8 March 2021 (third national lockdown).

Design: Retrospective data analysis.

View Article and Find Full Text PDF

Prevalence of microvascular complications and associated factors among diabetes mellitus patients in Ethiopia: A systematic review and Meta-analysis.

Microvasc Res

December 2024

Department of Medical Laboratory Science, College of Health Sciences, Woldia University, P.O. box 400, Woldia, Ethiopia; Research Center for Tuberculosis and Department of Medical Microbiology, Faculty of Health Sciences, University of Pretoria, Prinshof, 0084 Pretoria, South Africa.

Background: Diabetes mellitus (DM) is a metabolic abnormality affecting 537 million people worldwide. Poor glycemic control, longer duration, and poor medication adherence increased the risk of DM complications. Comprehensive evidence on the pooled prevalence of microvascular complications in DM patients in Ethiopia is not available.

View Article and Find Full Text PDF

Ginsenoside Ro prevents endothelial injury via promoting Epac1/AMPK- mediated mitochondria protection in early diabetic retinopathy.

Pharmacol Res

December 2024

Institute of Medicinal Plant Development, Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing, 100193, China; Beijing Key Laboratory of Innovative Drug Discovery of Traditional Chinese Medicine (Natural Medicine) and Translational Medicine; Key Laboratory of Bioactive Substances and Resource Utilization of Chinese Herbal Medicine, Ministry of Education. Electronic address:

Diabetic retinopathy (DR) is a blinding complication of microangiopathy. First-line therapeutic drugs are all focused on late-stage DR and have several side effects, which could not meet clinical needs. The plant-derived ginsenoside Ro (Ro) has a variety of effective anti-inflammatory, immune-regulating, and cardiovascular protective effects, but its microvascular protective effects are rarely studied.

View Article and Find Full Text PDF

This article reviews the critical issue of diabetic retinopathy (DR) in pregnant women with diabetes mellitus (DM), and describes the current understanding of the features of DM progression during pregnancy, as well as its pathogenic mechanisms, risk factors, and preventive measures for manifestation and progression of DR during gestation.

View Article and Find Full Text PDF

The introduction of faricimab, a drug targeting both vascular endothelial growth factor-A (VEGF-A) and angiopoietin-2, has enabled the implementation of the highly effective dual inhibition strategy in real clinical practice for patients with neovascular age-related macular degeneration (nAMD) and diabetic macular edema (DME), both previously treated with intravitreal injections and newly diagnosed. This article presents a series of 11 clinical cases involving patients with nAMD and DME who received loading doses of faricimab and continued ophthalmological observation. Among them, three patients with nAMD and two with DME were treatment-naïve, while the others were switched from alternative therapies to faricimab.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!